KLRK1 and breast carcinoma: Moreover, miR-519a-3p decreases NK cell-mediated killing of breast cancer cells by downregulating tumor cell ligands for the NK cell-activating receptor NKG2D and conferring resistance toward granzyme B- as well as TRAIL-induced apoptosis.